Title: 4 HOUSE BILL 2047 By: Stinson of the House
Official Title: 4 HOUSE BILL 2047 By: Stinson of the House
Number of Sections: 1
Source: versions - Floor (House)
Media Type: application/pdf
Strikethrough Detection: 7 sections found

================================================================================

Section 1:
1 HOUSE OF REPRESENTATIVES - FLOOR VERSION
2 STATE OF OKLAHOMA
3 1st Session of the 60th Legislature (2025)
5 and
6 Hines of the Senate
7
8
9 AS INTRODUCED
10 An Act relating to schools; creating the Emerson Kate
Cole Act; amending 70 O.S. 2021, Section 1-116.3,
11 which relates to school medication policies;
requiring school to call 911 if Epinephrine is
12 administered to a student; mandating school to notify
parent if student experiences possible allergic
13 reaction; requiring school districts to use model
policies; requiring annual training for certain
14 teachers and school employees; prescribing content
and method for training; providing for
15 noncodification; providing an effective date; and
declaring an emergency.
16
17
18 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
19 SECTION 1. NEW LAW A new section of law not to be
20 codified in the Oklahoma Statutes reads as follows:
21 This act shall be known and may be cited as the "Emerson Kate
22 Cole Act".
23 SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
24 amended to read as follows:
HB2047 HFLR Page 1
BOLD FACE denotes Committee Amendments.
1 Section 1-116.3. A. Notwithstanding the provisions of Section
2 1-116.2 of this title, the board of education of each school
3 district shall adopt a policy on or before September 1, 2008, that
4 permits the self-administration of inhaled asthma medication by a
5 student for treatment of asthma, the self-administration of
6 anaphylaxis medication by a student for treatment of anaphylaxis and
7 the self-administration of replacement pancreatic enzymes by a
8 student for treatment of cystic fibrosis. The policy shall require:
9 1. The parent or guardian of the student to authorize in
10 writing the student's self-administration of medication;
11 2. The parent or guardian of the student to provide to the
12 school a written statement from the physician treating the student
13 that the student has asthma, anaphylaxis or cystic fibrosis and is
14 capable of, and has been instructed in the proper method of, self-
15 administration of medication;
16 3. The parent or guardian of the student to provide to the
17 school an emergency supply of the student's medication to be
18 administered pursuant to the provisions of Section 1-116.2 of this
19 title;
20 4. The school district to inform the parent or guardian of the
21 student, in writing, that the school district and its employees and
22 agents shall incur no liability as a result of any injury arising
23 from the self-administration of medication by the student; and
24
HB2047 HFLR Page 2
BOLD FACE denotes Committee Amendments.
1 5. The parent or guardian of the student to sign a statement
2 acknowledging that the school district shall incur no liability as a
3 result of any injury arising from the self-administration of
4 medication by the student.
5 B. The school board of each school district that elects to
6 stock Epinephrine injectors or inhalers shall amend the policy
7 identified in subsection A of this section.
8 1. The amended policy for Epinephrine injectors shall require:
9 a. the school district to inform the parent or guardian
10 of each student, in writing, that a school nurse or
11 school employee trained by a health care professional
12 or trained in correlation with the State Department of
13 Health's Diabetes Management Annual School Training
14 Program may administer, with parent or guardian
15 permission but without a health care provider order,
16 an Epinephrine injection to a student whom the school
17 nurse or trained school employee in good faith
18 believes is having an anaphylactic reaction,
19 b. a waiver of liability executed by a parent or guardian
20 be on file with the school district prior to the
21 administration of an Epinephrine injection pursuant to
22 paragraph 1 of this subsection, and
23
24
HB2047 HFLR Page 3
BOLD FACE denotes Committee Amendments.
1 c. the school district to designate the employee
2 responsible for obtaining the Epinephrine injectors at
3 each school site.
4 2. The amended policy for inhalers shall require:
5 a. the school district to inform the parent or guardian
6 of each student, in writing, that a school nurse or
7 school employee trained by a health care professional
8 may administer an inhaler to a student whom the school
9 nurse or trained school employee in good faith
10 believes is having respiratory distress,
11 b. the school district to designate the employee
12 responsible for obtaining the inhalers and spacers or
13 holding chambers at each school site, and
14 c. the school district to notify the parent or guardian
15 of a student after administration of an inhaler.
16 C. The school district and its employees and agents shall incur
17 no liability as a result of any injury arising pursuant to the
18 discharge or nondischarge of the powers provided for pursuant to
19 subparagraph a of paragraphs 1 and 2 of subsection B of this
20 section.
21 D. A licensed physician who has prescriptive authority may
22 write a prescription for Epinephrine injectors and inhalers and
23 spacers or holding chambers to the school district in the name of
24 the district as a body corporate specified in Section 5-105 of this
HB2047 HFLR Page 4
BOLD FACE denotes Committee Amendments.
1 titl e which shall be maintained at each school site. Such physician
2 shall incur no liability as a result of any injury arising from the
3 use of the Epinephrine injectors or the inhalers and spacers or
4 holding chambers.
5 E. The school district may maintain at each school a minimum of
6 two Epinephrine injectors and two inhalers with spacers or holding
7 chambers in a secure location. Provided, however, that nothing in
8 this section shall be construed as creating or imposing a duty on a
9 school district to maintain Epinephrine injectors or inhalers with
10 spacers or holding chambers at a school site or sites.
11 F. In the event a student is believed to be having an
12 anaphylactic reaction or respiratory distress, a school employee
13 shall contact 911 as soon as possible. If Epinephrine is
14 administered to a student, a school employee shall contact 911 as
15 soon as possible. The school district shall notify the parent or
16 guardian of any student who experiences a possible allergic reaction
17 as soon as possible.
18 G. The State Board of Education, in consultation with the State
19 Board of Health, shall develop model policies which school districts
20 may shall use in compliance with this section. The model policies
21 shall include, at a minimum, required annual training for teachers
22 and school employees who are directly responsible for students on
23 the topics of food allergies, recognizing anaphylaxis, and
24 instruction on how to administer Epinephrine. The training shall be
HB2047 HFLR Page 5
BOLD FACE denotes Committee Amendments.
1 comp leted before the school year begins or upon hiring the teacher
2 or school employee. Documentation certifying completion of the
3 required training shall be retained in the personnel file of the
4 teacher or school employee. The training may be provided online or
5 in person by the school nurse or a recognized food allergy and
6 anaphylaxis training program.
7 H. The State Board of Education, in consultation with the State
8 Board of Health, shall promulgate rules to implement this section.
9 I. As used in this section:
10 1. "Medication" means a metered dose inhaler or a dry powder
11 inhaler to alleviate asthmatic symptoms, prescribed by a physician
12 and having an individual label, an anaphylaxis medication used to
13 treat anaphylaxis including but not limited to Epinephrine injectors
14 prescribed by a physician and having an individual label, or
15 replacement pancreatic enzymes prescribed by a physician and having
16 an individual label; and
17 2. "Self-administration" means a student's use of medication
18 pursuant to prescription or written direction from a physician.;
19 3. "Respiratory distress" means the perceived or actual
20 presence of coughing, wheezing or shortness of breath; and
21 4. "Inhaler" means a device that delivers a bronchodilator to
22 alleviate symptoms of respiratory distress that is manufactured in
23 the form of a metered-dose inhaler or dry-powder inhaler and that
24
HB2047 HFLR Page 6
BOLD FACE denotes Committee Amendments.
1 may include a spacer or holding chamber that attaches to the inhaler
2 to improve the delivery of the bronchodilator.
3 J. The permission for self-administration of asthma,
4 anaphylaxis or replacement pancreatic enzyme medication is effective
5 for the school year for which it is granted and shall be renewed
6 each subsequent school year upon fulfillment of the requirements of
7 this section.
8 K. A student who is permitted to self-administer asthma,
9 anaphylaxis or replacement pancreatic enzyme medication pursuant to
10 this section shall be permitted to possess and use a prescribed
11 inhaler, anaphylaxis medication including but not limited to an
12 Epinephrine injector, or replacement pancreatic enzyme medication at
13 all times.
14 SECTION 3. This act shall become effective July 1, 2025.
15 SECTION 4. It being immediately necessary for the preservation
16 of the public peace, health or safety, an emergency is hereby
17 declared to exist, by reason whereof this act shall take effect and
18 be in full force from and after its passage and approval.
19
20 COMMITTEE REPORT BY: COMMITTEE ON EDUCATION OVERSIGHT, dated
03/04/2025 - DO PASS, As Coauthored.
21
22
23
24
HB2047 HFLR Page 7
BOLD FACE denotes Committee Amendments.
[DELETED:  P B   a  ]
[DELETED:  P]
[DELETED:  P t a]
[DELETED:  P t t t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]


================================================================================

Raw Text:
1 HOUSE OF REPRESENTATIVES - FLOOR VERSION
2 STATE OF OKLAHOMA
3 1st Session of the 60th Legislature (2025)
4 HOUSE BILL 2047 By: Stinson of the House
5 and
6 Hines of the Senate
7
8
9 AS INTRODUCED
10 An Act relating to schools; creating the Emerson Kate
Cole Act; amending 70 O.S. 2021, Section 1-116.3,
11 which relates to school medication policies;
requiring school to call 911 if Epinephrine is
12 administered to a student; mandating school to notify
parent if student experiences possible allergic
13 reaction; requiring school districts to use model
policies; requiring annual training for certain
14 teachers and school employees; prescribing content
and method for training; providing for
15 noncodification; providing an effective date; and
declaring an emergency.
16
17
18 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
19 SECTION 1. NEW LAW A new section of law not to be
20 codified in the Oklahoma Statutes reads as follows:
21 This act shall be known and may be cited as the "Emerson Kate
22 Cole Act".
23 SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
24 amended to read as follows:
HB2047 HFLR Page 1
BOLD FACE denotes Committee Amendments.

1 Section 1-116.3. A. Notwithstanding the provisions of Section
2 1-116.2 of this title, the board of education of each school
3 district shall adopt a policy on or before September 1, 2008, that
4 permits the self-administration of inhaled asthma medication by a
5 student for treatment of asthma, the self-administration of
6 anaphylaxis medication by a student for treatment of anaphylaxis and
7 the self-administration of replacement pancreatic enzymes by a
8 student for treatment of cystic fibrosis. The policy shall require:
9 1. The parent or guardian of the student to authorize in
10 writing the student's self-administration of medication;
11 2. The parent or guardian of the student to provide to the
12 school a written statement from the physician treating the student
13 that the student has asthma, anaphylaxis or cystic fibrosis and is
14 capable of, and has been instructed in the proper method of, self-
15 administration of medication;
16 3. The parent or guardian of the student to provide to the
17 school an emergency supply of the student's medication to be
18 administered pursuant to the provisions of Section 1-116.2 of this
19 title;
20 4. The school district to inform the parent or guardian of the
21 student, in writing, that the school district and its employees and
22 agents shall incur no liability as a result of any injury arising
23 from the self-administration of medication by the student; and
24
HB2047 HFLR Page 2
BOLD FACE denotes Committee Amendments.

1 5. The parent or guardian of the student to sign a statement
2 acknowledging that the school district shall incur no liability as a
3 result of any injury arising from the self-administration of
4 medication by the student.
5 B. The school board of each school district that elects to
6 stock Epinephrine injectors or inhalers shall amend the policy
7 identified in subsection A of this section.
8 1. The amended policy for Epinephrine injectors shall require:
9 a. the school district to inform the parent or guardian
10 of each student, in writing, that a school nurse or
11 school employee trained by a health care professional
12 or trained in correlation with the State Department of
13 Health's Diabetes Management Annual School Training
14 Program may administer, with parent or guardian
15 permission but without a health care provider order,
16 an Epinephrine injection to a student whom the school
17 nurse or trained school employee in good faith
18 believes is having an anaphylactic reaction,
19 b. a waiver of liability executed by a parent or guardian
20 be on file with the school district prior to the
21 administration of an Epinephrine injection pursuant to
22 paragraph 1 of this subsection, and
23
24
HB2047 HFLR Page 3
BOLD FACE denotes Committee Amendments.

1 c. the school district to designate the employee
2 responsible for obtaining the Epinephrine injectors at
3 each school site.
4 2. The amended policy for inhalers shall require:
5 a. the school district to inform the parent or guardian
6 of each student, in writing, that a school nurse or
7 school employee trained by a health care professional
8 may administer an inhaler to a student whom the school
9 nurse or trained school employee in good faith
10 believes is having respiratory distress,
11 b. the school district to designate the employee
12 responsible for obtaining the inhalers and spacers or
13 holding chambers at each school site, and
14 c. the school district to notify the parent or guardian
15 of a student after administration of an inhaler.
16 C. The school district and its employees and agents shall incur
17 no liability as a result of any injury arising pursuant to the
18 discharge or nondischarge of the powers provided for pursuant to
19 subparagraph a of paragraphs 1 and 2 of subsection B of this
20 section.
21 D. A licensed physician who has prescriptive authority may
22 write a prescription for Epinephrine injectors and inhalers and
23 spacers or holding chambers to the school district in the name of
24 the district as a body corporate specified in Section 5-105 of this
HB2047 HFLR Page 4
BOLD FACE denotes Committee Amendments.

1 titl e which shall be maintained at each school site. Such physician
2 shall incur no liability as a result of any injury arising from the
3 use of the Epinephrine injectors or the inhalers and spacers or
4 holding chambers.
5 E. The school district may maintain at each school a minimum of
6 two Epinephrine injectors and two inhalers with spacers or holding
7 chambers in a secure location. Provided, however, that nothing in
8 this section shall be construed as creating or imposing a duty on a
9 school district to maintain Epinephrine injectors or inhalers with
10 spacers or holding chambers at a school site or sites.
11 F. In the event a student is believed to be having an
12 anaphylactic reaction or respiratory distress, a school employee
13 shall contact 911 as soon as possible. If Epinephrine is
14 administered to a student, a school employee shall contact 911 as
15 soon as possible. The school district shall notify the parent or
16 guardian of any student who experiences a possible allergic reaction
17 as soon as possible.
18 G. The State Board of Education, in consultation with the State
19 Board of Health, shall develop model policies which school districts
20 may shall use in compliance with this section. The model policies
21 shall include, at a minimum, required annual training for teachers
22 and school employees who are directly responsible for students on
23 the topics of food allergies, recognizing anaphylaxis, and
24 instruction on how to administer Epinephrine. The training shall be
HB2047 HFLR Page 5
BOLD FACE denotes Committee Amendments.

1 comp leted before the school year begins or upon hiring the teacher
2 or school employee. Documentation certifying completion of the
3 required training shall be retained in the personnel file of the
4 teacher or school employee. The training may be provided online or
5 in person by the school nurse or a recognized food allergy and
6 anaphylaxis training program.
7 H. The State Board of Education, in consultation with the State
8 Board of Health, shall promulgate rules to implement this section.
9 I. As used in this section:
10 1. "Medication" means a metered dose inhaler or a dry powder
11 inhaler to alleviate asthmatic symptoms, prescribed by a physician
12 and having an individual label, an anaphylaxis medication used to
13 treat anaphylaxis including but not limited to Epinephrine injectors
14 prescribed by a physician and having an individual label, or
15 replacement pancreatic enzymes prescribed by a physician and having
16 an individual label; and
17 2. "Self-administration" means a student's use of medication
18 pursuant to prescription or written direction from a physician.;
19 3. "Respiratory distress" means the perceived or actual
20 presence of coughing, wheezing or shortness of breath; and
21 4. "Inhaler" means a device that delivers a bronchodilator to
22 alleviate symptoms of respiratory distress that is manufactured in
23 the form of a metered-dose inhaler or dry-powder inhaler and that
24
HB2047 HFLR Page 6
BOLD FACE denotes Committee Amendments.

1 may include a spacer or holding chamber that attaches to the inhaler
2 to improve the delivery of the bronchodilator.
3 J. The permission for self-administration of asthma,
4 anaphylaxis or replacement pancreatic enzyme medication is effective
5 for the school year for which it is granted and shall be renewed
6 each subsequent school year upon fulfillment of the requirements of
7 this section.
8 K. A student who is permitted to self-administer asthma,
9 anaphylaxis or replacement pancreatic enzyme medication pursuant to
10 this section shall be permitted to possess and use a prescribed
11 inhaler, anaphylaxis medication including but not limited to an
12 Epinephrine injector, or replacement pancreatic enzyme medication at
13 all times.
14 SECTION 3. This act shall become effective July 1, 2025.
15 SECTION 4. It being immediately necessary for the preservation
16 of the public peace, health or safety, an emergency is hereby
17 declared to exist, by reason whereof this act shall take effect and
18 be in full force from and after its passage and approval.
19
20 COMMITTEE REPORT BY: COMMITTEE ON EDUCATION OVERSIGHT, dated
03/04/2025 - DO PASS, As Coauthored.
21
22
23
24
HB2047 HFLR Page 7
BOLD FACE denotes Committee Amendments.

[DELETED:  P B   a  ]
[DELETED:  P]
[DELETED:  P t a]
[DELETED:  P t t t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]